QA: Tetraphase Pharmaceuticals INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001373707_2015_Tetraphase_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001373707, Tetraphase Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 126,597,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 300,000
3 remainder_Assets 307,000
4 LiabilitiesCurrent 17,276,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,932,000
9 ResearchAndDevelopmentExpense 61,932,000
10 remainder_Expenses 0
11 remainder_Revenues 9,098,000
12 remainder_NetIncome -976,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 127,204,000
1 Liabilities 17,276,000
2 Expenses 74,864,000
3 Revenues 9,098,000
4 StockholdersEquity 109,928,000
5 NetIncome -66,742,000
6 ComprehensiveNetIncome -66,742,000
7 BaseVar 114,709,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.39
9 EconomicCapitalRatio 3.29

Edgar->Model Mapping

Feature Distribution

Change over Time